StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines intangible assets, net ($M) ($M)

Form 10-Q / 10-K (DB)

Latest, Q2 2026
61
Period ended Jun 30, 2026
Change on a year earlier
-6.0%
64.9 in Q2 2025
History
36 quarters
Since Q3 2017
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntangible assets, net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202661-6.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 202661.7+23.2%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 202562.7+22.7%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 202563.6+18.0%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 202564.9+20.9%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 202550.1-9.2%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 202451.1-10.5%Form 10-K (filed 2025-02-27) ↗
Q3 2024Sep 30, 202453.9+0.4%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 202453.7+14.5%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 202455.2+39.0%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 202357.1+40.6%Form 10-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 202353.7+31.6%Form 10-Q (filed 2023-11-09) ↗
Q2 2023Jun 30, 202346.9+8.3%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 202339.7-13.3%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 202240.6-13.1%Form 10-K (filed 2023-02-27) ↗
Q3 2022Sep 30, 202240.8+189.4%Form 10-Q (filed 2022-11-09) ↗

Cite this data

StockData. (2026). BeOne Medicines Intangible assets, net ($M) ($M), quarterly Q3 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_intang

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.